Cystatin C and interleukin‐6 for prognosticating patients with acute decompensation of cirrhosis

BACKGROUND AND AIM: Systemic inflammation and organ dysfunction/failure can complicate acute decompensation (AD) of cirrhosis with progression to acute‐on‐chronic liver failure (ACLF), leading to increased mortality. There are few studies on serum biomarkers predicting renal dysfunction (RD) or ACLF...

Descripción completa

Detalles Bibliográficos
Autores principales: Padia, Gaurav, Mahajan, Bhawana, Kumar, Ajay, Sonika, Ujjwal, Dahale, Amol S, Sachdeva, Sanjeev, Dalal, Ashok, George, Roshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035439/
https://www.ncbi.nlm.nih.gov/pubmed/33860096
http://dx.doi.org/10.1002/jgh3.12516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035439/
https://www.ncbi.nlm.nih.gov/pubmed/33860096
http://dx.doi.org/10.1002/jgh3.12516

Ejemplares similares